Adenine is a purine, one of the four nucleobases in the nucleic acid of DNA.

Tizanidine Hydrochloride is an α2‑adrenergic receptor agonist that inhibits the release of neurotransmitters from CNS norepinephrine‑activated neurons.

N-Acetyltizanidine is the N-acetylated derivative of tizanidine and is designated as Tizanidine USP Related Compound B.

1-Acetyl-2-imidazolidinone is an imidazolidinone pharmaceutical intermediate. It is designated as Clonidine EP Impurity A and serves as a reference standard for clonidine hydrochloride impurity profiling.

Traxoprodil is a potent and selective NMDA NR2B antagonist.

(1E,4E)-1,5-Bis(2-methoxyphenyl)penta-1,4-dien-3-one, also known as TFEB Activator 1 or curcumin analog C1, is an activator of transcription factor EB (TFEB) and is used as a research tool compound in molecular and chemical biology.

Combretastatin A4 is a microtubule-targeting agent that binds β-tubulin.

Nonivamide is a synthetic derivative of natural capsaicin and a TRPV1 agonist.

2-Thioadenosine (Cangrelor intermediate 1) is a selective A1 adenosine receptor (A1AR) ligand, is a key intermediate of cangrelor

Cangrelor Intermediate, chemically (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol (C16H22F3N5O4S2, MW 469.50), is a key chiral nucleoside-type intermediate in the synthesis of Cangrelor.

Osimertinib Mesylate Intermediate 1, chemically N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine (C20H16FN5O3, MW 393.37), is a key intermediate in the synthetic route to Osimertinib.

Osimertinib mesylate is a third‑generation EGFR inhibitor that suppresses the T790M resistance mutation generated by second‑generation EGFR inhibitors.

Olaparib Intermediate, chemically 2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid (C16H11FN2O3, MW 298.27), is a key carboxylic acid intermediate in the synthetic route to Olaparib.

Olaparib is a small molecule inhibitor of PARP1/PARP2, with weak inhibitory activity against PARP tankyrase‑1.

2-Bromo-5-hydroxybenzaldehyde is the versatile pharmaceutical intermediate/starting material for the API crisaborole and pexmetinib, and also for specialty and research synthesis.

4-(4-Bromo-3-formylphenoxy)benzonitrile is a key intermediate for Crisaborole.